AKT1 and neoplasm: Using a transgenic mouse model, Muller and co-workers demonstrated that mammary-specific expression of activated Akt1 accelerated ErbB2-induced mammary tumorigenesis by enhancing cyclin D1 and cell proliferation but suppressed lung metastases [87], suggesting Akt1 had opposite effects on tumor growth and metastases.